BLOOD RESEARCH

The Korean Society of Hematology (대한혈액학회)
권호 표지

Complications of a Totally Implanted Vascular Access Device (Chemoport) in Children with Malignancy

소아 종양 환아에서 발생한 완전 이식형 중심 정맥관과 관련된 합병증

Kim, Jung-Ok;Lee, Ji-Hye;Lee, Kun-Soo
김정옥;이지혜;이건수

  • Published : 20080900
⟨ Previous Next ⟩

Abstract

Background: Carefully using a totally implanted vascular access device and regular check-up of its condition in children who suffer with malignancy is very important. This study was performed to determine the complications related to using this device, according to the patient's age, gender and diagnosis, and the time from port insertion. Methods: We retrospectively studied 77 patients with malignancy (46 males and 31 females, age: 0.1∼18 years, mean age: 7.8 years) and they were treated with a totally implanted vascular access device (chemoport) from January 1996 to May 2007 in Kyungpook National University Hospital, Korea. We assessed the symptoms and radiologic findings, conducted blood tests and doppler USG; we found several complications and compared them according the patients’ age, gender and diagnosis. Results: Among the 77 cases with a totally implanted vascular access device (chemoport), 14 cases had complications related to the chemoport. Infections were detected in 8 cases. 6 of them had infections related to the chemoport after 4∼7 months from the port-insertion. After port removal and treatment with broad spectrum antibiotics, their symptoms such as fever and swelling were improved. Disconnection of the port was detected in 2 cases after 2 months and 22 months from port-insertion, respectively. These ports were successfully removed by cardiac catheterization. Rotation of the port was detected in one case after 9 months from port-insertion: the rotated port was removed. Obstruction with thrombus was detected in 3 cases, after 7∼16 months from port-insertion: this condition was treated with thrombolytic agents such urokinase and t-PA (tissue plasminogen activator), or surgical removal of the blood clot in the port site. Conclusion: To reduce the complications related to the totally implanted vascular access (device), such as infection, thrombosis and disconnection, we should carefully use this device and also regularly check its function and position. After completion of chemotherapy, removal of the port as soon as possible should be considered. If a complication is detected, then we should manage it immediately.

Keywords

References

  1. Niederhuber JE, Ensminger W, Gyves JW. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-12
  2. Dooley WC, Niederhuber JE. Establishing and maintaining vascular access. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical oncology. 2nd ed. Churchill Livingstone, 2000:755-75
  3. Lee YH. Clinical study of Hickman catheters in pediatric oncologic patients. J Korean Pediatr Soc 1996;39:682-90
  4. Park KD, Dong ES, Ha SH, et al. A prospective study of totally implanted venous access system in 19 children with cancer. J Korean Pediatric Soc 1993; 36:687-92
  5. Choi SH, Cho SH, Kim CJ, Kook H, Hwang TJ. Subclavian catheterization in the pediatric patients. J Korean Pediatr Soc 1997;40:368-74
  6. Lokich JJ, Bothe A Jr, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol 1985;3:710-7 https://doi.org/10.1200/JCO.1985.3.5.710
  7. Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ, Krzywda EA, Andris DA. Pinch-off syndrome: a complication of implanted subclavian venous access devices. Radiology 1990;177:353-6 https://doi.org/10.1148/radiology.177.2.2217768
  8. Lenglinger FX, Hartl P, Kirchgatterer A, Lenglinger GM, Baldinger C. Fracture and embolization of a central venous port catheter without prior compression between the clavicle and the 1st rib. Wien Klin Wochenschr 2001;113:134-7
  9. Wu JR, Hsu JH, Chang TT, Dai ZK, Lu CC, Wu DK. Nonsurgical percutaneous retrieval of dislodged Port-A catheters from pulmonary artery in children. Jpn Heart J 2002;43:295-300 https://doi.org/10.1536/jhj.43.295
  10. Neuling KF, Peet AC, Stevens MC, Donnell SC. Embolisation of an implanted venous catheter. Med Pediatr Oncol 2003;40:409-10 https://doi.org/10.1002/mpo.10204
  11. Behrend M, Paboura E, Raab R. Late embolization of an unfractured port catheter into the heart: report of a case. Surg Today 2002;32:724-6 https://doi.org/10.1007/s005950200135
  12. Roggla G, Linkesch M, Röggla M, Wagner A, Haber P, Linkesch W. A rare complication of a central venous catheter system (Port-a-Cath). A case report of a catheter embolization after catheter fracture during power training. Int J Sports Med 1993;14:345-6 https://doi.org/10.1055/s-2007-1021190
  13. Schwarz RE, Coit DG, Groeger JS. Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol 2000; 7:441-9 https://doi.org/10.1007/s10434-000-0441-y
  14. Balestreri L, De Cicco M, Matovic M, Coran F, Morassult S. Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study. Eur J Radiol 1995;20:108-11 https://doi.org/10.1016/0720-048X(95)00633-2
  15. Ray S, Stacey R, Imrie M, Frishie J. A review of 560 Hickman catheter insertions. Anaesthesia 19956;51: 951-5
  16. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348:1123-33 https://doi.org/10.1056/NEJMra011883
  17. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am 2005; 19:183-202 https://doi.org/10.1016/j.hoc.2004.09.007
  18. Lawson M, Bottino JC, Hurtibise MR. The use of urokinase to restore patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr 1982; 9:29-32
  19. Polderman KH, Girbes AR. Central venous catheter use. Part 2: infectious complications. Intensive Care Med 2002;28:18-28 https://doi.org/10.1007/s00134-001-1156-7
  20. Gupta H, Araki Y, Davidoff AM, et al. Evaluation of pediatric oncology patients with previous multiple central catheters for vascular access: is Doppler ultrasound needed? Pediatr Blood Cancer 2007;48:527- 31 https://doi.org/10.1002/pbc.20875
  21. Craft PS, May J, Dorigo A, Hoy C, Plant A. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. Aust NZJ Med 1996;26:33-9 https://doi.org/10.1111/j.1445-5994.1996.tb02904.x
  22. Randolph AG. Identification of central venous catheter- related infections in infants and children. Pediatr Crit Care Med 2005;6(3 Suppl):S19-24 https://doi.org/10.1097/01.PCC.0000161575.14769.93
  23. De Cicco M, Matovic M, Balestreri L, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997;86: 101-13 https://doi.org/10.1016/S0049-3848(97)00054-6
  24. Eastman ME, Khorsand M, Maki DG, et al. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2. Cancer 2001;91:806-14 https://doi.org/10.1002/1097-0142(20010215)91:4<806::AID-CNCR1068>3.0.CO;2-K
  25. Glaser DW, Medeiros D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. J Pediatr 2001;138:255-9 https://doi.org/10.1067/mpd.2001.111272